Wilson Sonsini Goodrich & Rosati represented Tenstorrent in the transaction. Tenstorrent announced that it closed a $100 million strategic financing up-round led by Hyundai Motor Group...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Humu on the transaction. Perceptyx announced it has acquired Humu, a technology company that uses science-based ‘nudges’ to influence positive behavior...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Tromzo in the transaction. Tromzo announced that it has secured an additional $8 million in an oversubscribed seed round led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Leap in the transaction. Leap announced it has secured a new capital raise totaling $12 million in equity financing. The funding...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in the transaction. The Longreach Group announced that it had, together with the founder family minority shareholders, completed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Forte Biosciences in the transaction. Forte Biosciences (NASDAQ: FBRX) announced key R&D updates for its product candidate FB-102 (a proprietary molecule...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Foresite Capital on the transaction. CG Oncology, Inc. announced the close of an oversubscribed $105 million crossover financing round, co-led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing Pacific Biosciences, and Fenwick & West is representing Apton Biosystems in the transaction. 8Pacific Biosciences of California (NASDAQ: PACB) (PacBio) announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Aurora Innovation, Inc. and Latham & Watkins represented the underwriters in the offering. Aurora Innovation, Inc. (Nasdaq: AUR) announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Versant Ventures and New Enterprise Associates on the deal. Nexo Therapeutics (Nexo) announced it has emerged from stealth with $60 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Collaborative Robotics in the transaction. Collaborative Robotics announced it has raised $30M in Series A funding led by new lead investor, Sequoia Capital,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati served as special company counsel to Certinia in this transactio Haveli Investments announced that it has entered into a definitive agreement to...
You must be a Standard 1 Year member to access this content.
